...
首页> 外文期刊>Nanoscale >Nanonet-nano fiber electrospun mesh of PCL-chitosan for controlled and extended release of diclofenac sodium
【24h】

Nanonet-nano fiber electrospun mesh of PCL-chitosan for controlled and extended release of diclofenac sodium

机译:Nanonet-nano实际上电纺纤维的网状PCL-chitosan控制和扩展双氯芬酸钠

获取原文
获取原文并翻译 | 示例

摘要

Electrospun nanofiber (EN) technology has been used in the past to generate electrostatically charged multilayer-nanofibers. This platform offers versatile applications including in tissue engineering, drug delivery, wound dressings, and high-efficiency particulate air filters. In this study, we synthesized for the first time nanonet-nanofiber electrospun meshes (NNEMs) of polycaprolactone (PCL)-chitosan (CH) using EN technology. The fabricated NNEMs were utilized for high payload delivery and controlled release of a water-soluble drug. Diclofenac Sodium (DS), a hydrophilic anti-inflammatory drug, was selected as a model drug because of its high aqueous solubility and poor compatibility with insoluble polymers. Various compositions of DS drug-loaded NNEMs (DS-NNEMs) were synthesized. The physicochemical properties such as structure, morphology, and aqueous stability and the chemical properties of DS-NNEMs were evaluated. High drug entrapment efficiency and concentration-dependent drug release patterns were investigated for up to 14 days. Furthermore, the biocompatibility of the DS-NNEMs was tested with NIH 3T3 cells. The physicochemical characterization results showed that the DS drug is a key contributing factor in the generation of nanonet-nanofiber networks during electrospinning. DS-NNEMs also enhanced 3T3 cell adhesion, viability, and proliferation in the nanonet-nano fiber network through the controlled release of DS. The presented EN technology-based biodegradable NNEM material is not only limited for the controlled release of hydrophilic anti-inflammatory drugs, but also can be a suitable platform for loading and release of antiviral drugs.
机译:实际上电纺纳米纤维(EN)技术过去用来产生静电multilayer-nanofibers指控。提供通用的应用程序包括在组织工程、药物输送、伤口敷料和高效微粒空气过滤器。研究中,我们首次合成nanonet-nanofiber实际上电纺网格(NNEMs)聚已酸内酯(PCL)壳聚糖(CH)使用技术。对于高负载交付和控释水溶性药物。一个亲水的抗炎药物,选为模型药物,因为它高水溶解度和可怜的兼容不溶性聚合物。药物NNEMs (DS-NNEMs)是合成的。结构等物理化学性质,形态和水稳定性和化学性质DS-NNEMs被评估。药物截留效率高浓度药物释放模式研究了14天。DS-NNEMs的生物相容性进行了测试NIH 3 t3细胞。表征结果表明,DS药物是一个关键的因素在一代的吗nanonet-nanofiber网络在电纺的。附着力、可行性和扩散通过控制nanonet-nano光纤网络DS的释放。可生物降解NNEM材料不仅是有限的对亲水的控制释放抗炎药,但也可以合适的装载和释放的平台抗病毒药物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号